StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Shift - Our new media partner and our new rep

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jun 02, 2021 12:41pm

71 Views

Post# 33311266

RE:Shift - Our new media partner and our new rep

Some of Shift's customers:

Citrix, McDonald's, Scotties, Shutterstock, Merck, GoDaddy,Evite, Randstad

https://www.shiftcomm.com/work/

LithLover wrote:
Kristin Villiotte

Vice President, Healthcare

As Vice President of SHIFT’s Healthcare practice, Kristin provides senior communications strategy and counsel for companies across the healthcare spectrum. She has more than 15 years of experience developing and executing creative communications programs that support increased brand awareness, corporate visibility, scientific exchange and competitive positioning. Throughout her career, Kristin has helped healthcare, medical device, health technology and biopharmaceutical industry clients gain valuable market visibility through impactful, integrated communications campaigns. She has represented a broad range of companies — from innovative startups to global pharmaceutical brands — including Merck/EMD Serono, Welltok and Healthify.

https://www.shiftcomm.com/

For further information please contact:

Investor Relations
Rebecca Greco
Tel: 1-855-420-7140 ext. 1838
rgreco@stagezerols.com

Media Contact
Kristin Villiotte
SHIFT Communications
kvilliotte@shiftcomm.com